Your browser doesn't support javascript.
loading
Sleep apnea and the impact on cardiovascular risk in patients with Marfan syndrome.
Muiño-Mosquera, Laura; Bauters, Fré; Dhondt, Karlien; De Wilde, Hans; Jordaens, Luc; De Groote, Katya; De Wolf, Daniel; Hertegonne, Katrien; De Backer, Julie.
Afiliación
  • Muiño-Mosquera L; Centre for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
  • Bauters F; Department of Pediatrics, Division of Pediatric Cardiology, Ghent University Hospital, Ghent, Belgium.
  • Dhondt K; Department of Pneumology, Ghent University Hospital, Ghent, Belgium.
  • De Wilde H; Department of Pneumology, Ghent University Hospital, Ghent, Belgium.
  • Jordaens L; Department of Psychiatry, Division of Child and Adolescent Psychiatry, Pediatric Sleep Centre, Ghent University Hospital, Ghent, Belgium.
  • De Groote K; Department of Pediatrics, Division of Pediatric Cardiology, Ghent University Hospital, Ghent, Belgium.
  • De Wolf D; Department of Cardiology, Ghent University Hospital, Ghent, Belgium.
  • Hertegonne K; Department of Cardiology, Ghent University Hospital, Ghent, Belgium.
  • De Backer J; Department of Pediatrics, Division of Pediatric Cardiology, Ghent University Hospital, Ghent, Belgium.
Mol Genet Genomic Med ; 7(8): e805, 2019 08.
Article en En | MEDLINE | ID: mdl-31245936
ABSTRACT

BACKGROUND:

Marfan syndrome (MFS) is an inherited connective tissue disorder characterized by ectopia lentis, aortic root dilation and dissection and specific skeletal features. Obstructive sleep apnea (OSA) in MFS has been described earlier but the prevalence and its relation with the cardiovascular risk is still controversial. This study aimed to further investigate these aspects.

METHODS:

In this prospective longitudinal study, we performed an attended polysomnography in 40 MFS patients (60% women, 37 ± 12.8 years) and evaluated several cardiovascular parameters through echocardiography, resting electrocardiogram, 24 hr-Holter monitoring and serum NT-ProBNP measurements.

RESULTS:

We found that OSA was present in 42.5% of the patients and that higher body mass index was the most important factor associated with the presence of OSA. We observed that overweight was present in 27.5% of the patients in the whole cohort and in 55.6% if >40 years. Furthermore, when evaluating the impact of OSA on the cardiovascular system, we observed that patients with OSA tended to have higher systolic blood pressure, larger distal aortic diameters and a higher prevalence of ventricular arrhythmia. These differences were, however, not significant after adjusting for confounders.

CONCLUSIONS:

Our study shows a high prevalence of OSA and a high prevalence of overweight in MFS patients. We found some trends between OSA and cardiovascular features but we could not establish a solid association. Our study, however might be underpowered, and a multicenter collaborative study could be very useful to answer some important open questions.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndromes de la Apnea del Sueño / Enfermedades Cardiovasculares / Síndrome de Marfan Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Mol Genet Genomic Med Año: 2019 Tipo del documento: Article País de afiliación: Bélgica

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndromes de la Apnea del Sueño / Enfermedades Cardiovasculares / Síndrome de Marfan Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Mol Genet Genomic Med Año: 2019 Tipo del documento: Article País de afiliación: Bélgica